EYEGATE PHARMACEUTICALS INC 4
4 · EYEGATE PHARMACEUTICALS INC · Filed Feb 23, 2015
Insider Transaction Report
Form 4
HANCOCK THOMAS
Director
Transactions
- Award
Stock Option (right to buy)
2015-02-19+2,276→ 2,276 totalExercise: $6.00Exp: 2025-02-19→ Common Stock (2,276 underlying)
Footnotes (1)
- [F1]The option became exercisable as to 33% of the shares underlying the option on April 24, 2014 and the remaining balance vests monthly on the first day of each calendar month thereafter.